(7R,8R,9R) 7-Methoxy-8-methoxycarbonyloxy-2,3-dimethyl-9-phenyl7,8,9,10-tetrahydroimidazo[1,2-h][1,7]naphthyridine | 362525-62-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 英文名称: (7R,8R,9R) 7-Methoxy-8-methoxycarbonyloxy-2,3-dimethyl-9-phenyl7,8,9,10-tetrahydroimidazo[1,2-h][1,7]naphthyridine
• 英文别名: [(7R,8R,9R)-7-methoxy-2,3-dimethyl-9-phenyl-7,8,9,10-tetrahydroimidazo[1,2-h][1,7]naphthyridin-8-yl] methyl carbonate
• CAS: 362525-62-0
• 化学式: C₂₁H₂₃N₃O₄
• 分子量: 381.431
• InChiKey: PQYOFNTUPBMMJT-BHIYHBOVSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  28
• 可旋转键数：
  5
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  74.1
• 氢给体数：
  1
• 氢受体数：
  6

文献信息

• Prodrugs of imidazopyridine derivatives
  申请人：——

  公开号：US20030125327A1

  公开（公告）日：2003-07-03

  Compounds of formula (1), in which the substituents have the meanings mentioned in the description are suitable for the prevention and treatment of gastrointestinal diseases. 1

  式（1）化合物，其中取代基具有描述中提到的含义，适用于预防和治疗胃肠疾病。
• [EN] PRODRUGS OF IMIDAZOPYRIDINE DERIVATIVES<br/>[FR] PROMEDICAMENTS DE DERIVES D'IMIDAZOPYRIDINE
  申请人：BYK GULDEN LOMBERG CHEM FAB

  公开号：WO2001072756A1

  公开（公告）日：2001-10-04

  Compounds of formula (1), in which the substituents have the meanings mentioned in the description are suitable for the prevention and treatment of gastrointestinal diseases.

  公式（1）的化合物，其中取代基具有描述中提到的含义，适用于预防和治疗胃肠疾病。
• Aminomethylpyrrolidine derivatives having aromatic substituents
  申请人：DAIICHI PHARMACEUTICAL CO., LTD.

  公开号：US20040209940A1

  公开（公告）日：2004-10-21

  This invention provides a quinolone derivative having potent antibacterial activity against various bacteria including drug-resistant strains which is a compound of the following formula wherein R 1 is an optionally substituted aromatic group, a salt of the same or a hydrate of both. 1 In the formula, R 2 , R 3 : hydrogen atom, an alkyl group; R 4 , R 5 , R 6 : hydrogen atom, hydroxyl group, a halogen atom, carbamoyl group, an alkyl group, an alkoxyl group, an alkylthio group; R 7 , R 8 : hydrogen atom, an alkyl group; R 9 : an alkyl group, an alkenyl group, a halogenoalkyl group, a cyclic alkyl group, an aryl group, a heteroaryl group, an alkoxyl group having from 1 to 6 carbon atoms, an alkylamino group; R 10 :hydrogen atom, an alkylthio group; R 11 : hydrogen atom, amino group, hydroxyl group, thiol group, a halogenomethyl group, an alkyl group, an alkenyl group, an alkynyl group, an alkoxyl group; X 1 : halogen atom, a hydrogen atom; A 1 : nitrogen atom, C-X 2 ; X 2 : hydrogen atom, amino group, a halogen atom, cyano group, an halogenomethyl group, a halogenomethoxyl group, an alkyl group, an alkenyl group, an alkynyl group, an alkoxyl group; A 2 , A 3 :>C═C (-A 1 ═)—N(—R 9 )—, >N—C (-A 1 >)═C(—R 9 )—; R 10 and R 9 or R 9 and X 2 may be integrated to for a ring structure; and Y: hydrogen atom, ester forming group.

  本发明提供了一种喹诺酮衍生物，其具有强效的抗菌活性，可用于治疗包括耐药菌株在内的各种细菌感染。该化合物的结构式如下：其中R1为可选的取代芳基，其盐或水合物。在公式中，R2、R3：氢原子、烷基；R4、R5、R6：氢原子、羟基、卤素原子、氨基甲酰基、烷基、烷氧基、烷硫基；R7、R8：氢原子、烷基；R9：烷基、烯基、卤代烷基、环烷基、芳基、杂环芳基、含有1~6个碳原子的烷氧基、烷基氨基；R10：氢原子、烷硫基；R11：氢原子、氨基、羟基、硫醇基、卤代甲基基、烷基、烯基、炔基、烷氧基；X1：卤素原子、氢原子；A1：氮原子、C-X2；X2：氢原子、氨基、卤素原子、氰基、卤代甲基基、卤代甲氧基基、烷基、烯基、炔基、烷氧基；A2、A3：>C=C(-A1H)-N(-R9)-、>N-C(-A1>)=CH(-R9)-；R10和R9或R9和X2可以结合形成环状结构；Y：氢原子、酯形成基。
• Combinations and use of selected pharmaceutically active compounds
  申请人：Buhr Wilm

  公开号：US20060154954A1

  公开（公告）日：2006-07-13

  The present invention relates to new combinations and new uses of certain selected tricyclic imidazo [ 1,2 -a]pyridine compounds in the prevention or treatment of medicament caused gastrointestinal diseases.

  本发明涉及某些精选三环咪唑[1,2]的新组合和新用途。 1,2 -a]吡啶化合物在预防或治疗药物引起的胃肠道疾病方面的新组合和新用途。
• Oral pharmaceutical preparation for proton pump antagonists
  申请人：Dietrich Rango

  公开号：US20060204568A1

  公开（公告）日：2006-09-14

  The invention relates to novel dosage forms for proton pump antagonists.

  本发明涉及质子泵拮抗剂的新型剂型。